Close Menu

This article has been updated from a previous version to clarify the nature of the partnership between Evosep and Thermo Fisher.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Evosep announced on Monday a partnership to develop and promote workflows for clinical proteomics.

The collaboration will be centered out of Thermo Fisher's Boston-based Precision Medicine Science Center and will combine its mass spec systems with Evosep's liquid chromatography to develop robust, high-throughput clinical proteomic methods, the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.